Form 483

Laboratorios Dr. Collado, S.A. Form 483, 2023-04-21

FDA issued a Form 483 to Laboratorios Dr. Collado, S.A. on 2023-04-21 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Laboratorios Dr. Collado, S.A. · Santo Domingo Norte, Dominican Republic (the) · Issued April 21, 2023

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Apr 2023
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Susanna E Ford, Clinton J Lott

21 Apr 2023
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Susanna E Ford, Clinton J Lott

21 Apr 2023
21 CFR 211.192

No written record of investigation

Cited by Susanna E Ford, Clinton J Lott

21 Apr 2023
21 CFR 211.25(a)

GMP Training Frequency

Cited by Susanna E Ford, Clinton J Lott

21 Apr 2023
21 CFR 211.25(c)

Inadequate number of personnel

Cited by Susanna E Ford, Clinton J Lott

Inspected site

LDLaboratorios Dr. Collado, S.A.Santo Domingo Norte, Dominican Republic (the)

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(c)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere